Pegasystems
325 Case Studies
A Pegasystems Case Study
The global biotech company faced the challenge of complying with the FDA's REMS mandate, which required a patient-focused system to manage the risks of its high-risk therapies. Its existing systems were not agile enough to synchronize patient diagnostic results with pharmacy medication releases, a necessity for both compliance and patient safety. To address this, the company partnered with Pegasystems and utilized its Customer Service application for digital process automation.
Pegasystems delivered a fully integrated, end-to-end solution that streamlined the registration, prescription, and dispensing processes across multiple channels. This resulted in a 30% increase in efficiencies and reduced annual program costs by $1.5 million. Most importantly, the solution from Pegasystems ensured demonstrable real-time compliance, improved the patient experience by guaranteeing timely access to therapies, and provided the agility to adapt to changing regulatory needs in days instead of months.
Global Biotech Company